enVVeno Medical (NVNO) Net Shares Issued and Repurchased (2018 - 2026)

enVVeno Medical has reported Net Shares Issued and Repurchased for 9 years, with the latest figure at $7.8 million in Q2 2026.

• On a quarterly basis, Net Shares Issued and Repurchased fell 54.21% year-over-year to $7.8 million in Q2 2026; TTM through Jun 2026 was $7.8 million, a 54.21% decrease from a year earlier, with the FY2025 full-year figure at $33000.0, down 5.71% from the prior year.
• Net Shares Issued and Repurchased was $7.8 million for Q2 2026 at enVVeno Medical, up from $4.5 million in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $423.0 million in Q2 2024, with the low at $33000.0 in Q4 2025.
• Average Net Shares Issued and Repurchased over 5 years is $50.6 million, with a median of $3.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Net Shares Issued and Repurchased plunged 99.99% in 2022, then surged 2400.0% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $413612.0 in 2022, then jumped by 148.16% to $1.0 million in 2023, then tumbled by 96.59% to $35000.0 in 2024, then retreated by 5.71% to $33000.0 in 2025, then soared by 23687.88% to $7.8 million in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $7.8 million (Q2 2026), $4.5 million (Q1 2026), and $33000.0 (Q4 2025), per Business Quant data.